PTPRC and neoplasm: Similarly, the levels of CD11b + myeloid cells and CD3+ T-cells remained fairly constant over the course of tumor growth, with only a slight decrease in myeloid cells and a slight increase in T-cells as a proportion of CD45+ cells at day 10.